Projects funded by the NCN
Comparison of cardioprotective effects of metformin and resveratrol on cardiomyocytes treated with epirubicin and trastuzumab.
2012/05/N/NZ7/01936
Keywords:
cardiomyocytes cardiac stem cells cardioprotection breast cancer epirubicin trastuzumab
Descriptors:
- NZ7_12: Prevention of human diseases
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_15: Toxicology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Fundacja Rozwoju Kardiochirurgii im. prof. Z Religi
woj. śląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 3 - announced on 2012-03-15
Amount awarded: 149 730 PLN
Project start date (Y-m-d): 2013-04-11
Project end date (Y-m-d): 2014-12-22
Project duration:: 20 months (the same as in the proposal)
Project status: Project settled